2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summit
02-03

October 2018

Austria

Vienna

Hilton Garden Inn Vienna South

Hertha-Firnberg-Straße 5, 1100

Co-located with Immuno-Oncology & Dx

We are pleased to invite you to the 2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summit scheduled for October 2nd 3rd, 2018 in Vienna, Austria. This Summit is co-located with Immuno-Oncology & 4th Annual Biomarkers - CDx - Precision Immunotherapy Summits. The co-located Summits will bring together decision makers and industry leaders with both scientific and commercial interests to expand the scientific horizons of Biomarkers, Precision Medicine, Companion Dx, Immuno-Oncology and Microbiome, and will shed the light...

We are pleased to invite you to the 2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summit scheduled for October 2nd 3rd, 2018 in Vienna, Austria. This Summit is co-located with Immuno-Oncology & 4th Annual Biomarkers - CDx - Precision Immunotherapy Summits. The co-located Summits will bring together decision makers and industry leaders with both scientific and commercial interests to expand the scientific horizons of Biomarkers, Precision Medicine, Companion Dx, Immuno-Oncology and Microbiome, and will shed the light on the latest advancements and improvements in research and development, business opportunities in partnering, and investment. We will discuss key findings, critical insights, as well as recommendations for accelerating development in the field. We are excited to be hosting these Summits in Vienna and we look forward to welcoming you in October.

more info
Who Should Attend

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, and Managers specialising in:

  • Microbiome/Microbiota
  • Microbiology
  • Computational biology
  • Autoimmune Disease
  • Infectious Diseases
  • Inflammation
  • Food/Nutrition Science
  • Genotyping
  • Biomarkers
  • Data Management
  • Metagenomics
  • High-Throughput Screening
  • Diagnostic & Clinical Applications
  • Licensing or Technology Transfer
  • Regulatory
  • Clinical trials
  • Bacteria / Fungi / Viruses
  • Molecular Biology
  • Molecular Diagnostics
  • Immuno-oncology
  • Metabolic Disease
  • Vaccines
  • Neurodegeneration / Gut-Brain Axis
  • Genomics
  • Bioinformatics
  • Epigenetics
  • NGS
  • Personalized / Targeted Therapeutics
  • Venture Capitalists
  • Business Development/In-Licensing
  • Market Access
Key Practical Learning Points of the Summit

Emerging science and technologies for successful Microbiome discovery and translation
Commercialization and investment perspectives of Microbiome – based diagnostics and therapeutics
Clinical applications of Microbiome in oncology & beyond
Regulatory compliance for Microbiome drugs
Translation of Microbiome products:
Into clinical trials
For healthy nutrition
Into personalized therapeutics and diagnostic
Speakers
Dr. Barbara Joyce-Shaikh, US

Project Leader, Discovery Research

Merck Research Laboratories

Dr. Oliver Chao, FR

Head, Emerging Biomedical Sciences Strategy & Innovation

Sanofi

Dr. Bram Vanparys, NL

Investment Director, Healthcare

Merck Ventures B.V

Dr. Jesús Zurdo, UK

Sr Director Strategic Innovation Future Technologies

Lonza Biologics plc

Dr. Frédéric Baribaud, US

Scientific Director

Janssen R&D

Dr. Nicholas Monsul, US

CEO & Co-Founder

Quorum Innovations, LLC

Dr. Olga Sakwinska, CH

Research Scientist, Host Microbe Interaction Group / Institute of Nutritional Science Nestec Ltd.

Nestlé Research Center

Dr. Colette Shortt, UK

Consumer Fellow, Regulatory Director

J&J Consumer

Dr. Kristin Wannerberger, CH

Director Alliance Management R&D

Ferring Pharmaceuticals

Dr. Audrey Gueniche, FR

Clinical Scientific Coordinator / Senior Expert, Advanced Research

L’Oréal Research & Innovation

Dr. Jean de Gunzburg, UK

Chief Scientific Officer

Da Volterra

Dr. Patrice Garnier, FR

Chief Executive Officer

Amabiotics

Dr. Shahram Lavasani, SE

Founder & CEO

ImmuneBiotech AB

Dr. Gregory Lambert, FR

CEO – VP R&D

TargEDys SA

Dr. Imke Mulder, UK

Research Director

4D Pharma Research Ltd.

Dr. Ylaine Gerardin, US

Data Scientist

Finch

Dr. Gianluca Ianiro, IT

Internal Medicine, Gastroenterology and Liver Unit

Agostino Gemelli University Polyclinic / Università Cattolica del Sacro Cuore

Dr. Morten L. Isaksen, NO

Founder & CEO

Bio-Me AS

Annual

Events

Sponsors and Partners

Sponsor

Partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner